ArticleEuropean journal of neurology2021

Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel.

Itay Lotan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.